ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

June 25, 1982

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001